These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9790153)

  • 1. Alprazolam 0.125 mg twice a day improves aspects of psychometric performance in healthy volunteers.
    Bourin M; Colombel MC; Guitton B
    J Clin Psychopharmacol; 1998 Oct; 18(5):364-72. PubMed ID: 9790153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lorazepam 0.25 mg twice a day improves aspects of psychometric performance in healthy volunteers.
    Bourin M; Colombel MC; Malinge M
    J Psychopharmacol; 1995 Jan; 9(3):251-7. PubMed ID: 22297765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers.
    Hindmarch I; Trick L; Ridout F
    Psychopharmacology (Berl); 2005 Dec; 183(2):133-43. PubMed ID: 16205916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The cognitive effect of alprazolam in healthy volunteers].
    Drabant S; Tömlo J; Tóth M; Péterfai E; Klebovich I
    Acta Pharm Hung; 2006; 76(1):25-31. PubMed ID: 17094673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers.
    Hindmarch I; Shamsi Z; Kimber S
    Clin Exp Allergy; 2002 Jan; 32(1):133-9. PubMed ID: 12002730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of buspirone and alprazolam on the cognitive performance of normal elderly subjects.
    Hart RP; Colenda CC; Hamer RM
    Am J Psychiatry; 1991 Jan; 148(1):73-7. PubMed ID: 1984710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function.
    Hindmarch I; Shamsi Z; Stanley N; Fairweather DB
    Br J Clin Pharmacol; 1999 Aug; 48(2):200-6. PubMed ID: 10417497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the psychomotor and antistress effects of ritanserin, alprazolam and diazepam in healthy subjects: some trait anxiety-independent responses.
    Danjou P; Warot D; Hergueta T; Lacomblez L; Bouhours P; Puech AJ
    Int Clin Psychopharmacol; 1992 Nov; 7(2):73-9. PubMed ID: 1487624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of repeated doses of clomipramine and alprazolam on physiological, psychomotor and cognitive functions in normal subjects.
    Allen D; Curran HV; Lader M
    Eur J Clin Pharmacol; 1991; 40(4):355-62. PubMed ID: 2050170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A preliminary investigation on the acute pharmacodynamic effects of hypericum on cognitive and psychomotor performance.
    Timoshanko A; Stough C; Vitetta L; Nathan PJ
    Behav Pharmacol; 2001 Dec; 12(8):635-40. PubMed ID: 11856901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Chronic Alprazolam Intake on Memory, Attention, and Psychomotor Performance in Healthy Human Male Volunteers.
    Chowdhury ZS; Morshed MM; Shahriar M; Bhuiyan MA; Islam SM; Bin Sayeed MS
    Behav Neurol; 2016; 2016():3730940. PubMed ID: 27462136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamics of milnacipran in young and elderly volunteers.
    Hindmarch I; Rigney U; Stanley N; Briley M
    Br J Clin Pharmacol; 2000 Feb; 49(2):118-25. PubMed ID: 10671905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A statistical approach for classifying change in cognitive function in individuals following pharmacologic challenge: an example with alprazolam.
    Maruff P; Werth J; Giordani B; Caveney AF; Feltner D; Snyder PJ
    Psychopharmacology (Berl); 2006 May; 186(1):7-17. PubMed ID: 16572266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral effects of alprazolam in humans.
    Kelly TH; Foltin RW; Serpick E; Fischman MW
    Behav Pharmacol; 1997 Feb; 8(1):47-57. PubMed ID: 9833000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abuse liability assessment of eslicarbazepine acetate in healthy male and female recreational sedative users: A Phase I randomized controlled trial.
    Levy-Cooperman N; Schoedel KA; Chakraborty B; Blum D; Cheng H
    Epilepsy Behav; 2016 Aug; 61():63-71. PubMed ID: 27315134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo.
    Hindmarch I; Dawson J; Stanley N
    Sleep; 2005 Feb; 28(2):187-93. PubMed ID: 16171242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers.
    Hallam KT; Olver JS; McGrath C; Norman TR
    Hum Psychopharmacol; 2003 Dec; 18(8):619-25. PubMed ID: 14696021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human abuse potential of brivaracetam in healthy recreational central nervous system depressant users.
    Schoedel KA; Stockis A; Sellers EM
    Epilepsy Behav; 2018 Jan; 78():194-201. PubMed ID: 29153631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coadministration of nefazodone and benzodiazepines: I. Pharmacodynamic assessment.
    Kroboth PD; Folan MM; Lush RM; Chaikin PC; Shukla UA; Barbhaiya R; Salazar DE
    J Clin Psychopharmacol; 1995 Oct; 15(5):306-19. PubMed ID: 8830061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the spectrum of cognitive effects of alprazolam and adinazolam after single doses in healthy subjects.
    Fleishaker JC; Garzone PD; Chambers JH; Sirocco K; Weingartner H
    Psychopharmacology (Berl); 1995 Jul; 120(2):169-76. PubMed ID: 7480549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.